U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 99

Variation
Gene
(Protein Change)
Type
(Consequence)
ConditionClassification, Review status
CD2AP, CD2AP-DT
+1 more
Single nucleotide variant
(5 prime UTR variant)
not provided
+1 more
GBenign
CD2AP, CD2AP-DT
+1 more
Single nucleotide variant
(5 prime UTR variant)
not provided
+1 more
GBenign/Likely benign
CD2AP, CD2AP-DT
+1 more
Single nucleotide variant
(5 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP, CD2AP-DT
+1 more
Single nucleotide variant
(5 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP, CD2AP-DT
+1 more
Single nucleotide variant
(5 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP, CD2AP-DT
+1 more
Single nucleotide variant
(5 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GBenign
CD2AP, CD2AP-DT
+1 more
Single nucleotide variant
(5 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GBenign
CD2AP, CD2AP-DT
+1 more
Single nucleotide variant
(5 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP, CD2AP-DT
+1 more
Single nucleotide variant
(5 prime UTR variant)
not provided
+1 more
GBenign
CD2AP, CD2AP-DT
+1 more
Single nucleotide variant
(5 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(5 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(5 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(5 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(5 prime UTR variant)
not provided
+1 more
GBenign
CD2AP
Single nucleotide variant
(intron variant)
not provided
+1 more
GBenign/Likely benign
CD2AP
(T61M)
Single nucleotide variant
(missense variant)
not provided
+2 more
GUncertain significance
CD2AP
Single nucleotide variant
(synonymous variant)
not specified
+3 more
GBenign/Likely benign
CD2AP
(R74M)
Single nucleotide variant
(missense variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
(K109R)
Single nucleotide variant
(missense variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
(I134V)
Single nucleotide variant
(missense variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
(I134N)
Single nucleotide variant
(missense variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
(N151S)
Single nucleotide variant
(missense variant)
Focal segmental glomerulosclerosis 3, susceptibility to
+1 more
GConflicting classifications of pathogenicity
CD2AP
(Q177R)
Single nucleotide variant
(missense variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(intron variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(intron variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
(A185S)
Single nucleotide variant
(missense variant)
Focal segmental glomerulosclerosis 3, susceptibility to
+1 more
GConflicting classifications of pathogenicity
CD2AP
Single nucleotide variant
(synonymous variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
(R228W)
Single nucleotide variant
(missense variant)
CD2AP-related condition
+2 more
GConflicting classifications of pathogenicity
CD2AP
Single nucleotide variant
(synonymous variant)
not provided
+3 more
GBenign/Likely benign
CD2AP
Single nucleotide variant
(intron variant)
not provided
+1 more
GLikely benign
CD2AP
(K253E)
Single nucleotide variant
(missense variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(synonymous variant)
not provided
+2 more
GBenign/Likely benign
CD2AP
Single nucleotide variant
(intron variant)
not provided
+2 more
GBenign
CD2AP
Single nucleotide variant
(synonymous variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
(L331H)
Single nucleotide variant
(missense variant)
not provided
+1 more
GConflicting classifications of pathogenicity
CD2AP
Single nucleotide variant
(synonymous variant)
CD2AP-related condition
+2 more
GBenign/Likely benign
CD2AP
(T374A)
Single nucleotide variant
(missense variant)
not provided
+3 more
GBenign/Likely benign
CD2AP
(A383E)
Single nucleotide variant
(missense variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(synonymous variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
(P394Q)
Single nucleotide variant
(missense variant)
not provided
+1 more
GBenign/Likely benign
CD2AP
Single nucleotide variant
(synonymous variant)
not provided
+1 more
GLikely benign
CD2AP
Single nucleotide variant
(synonymous variant)
not provided
+2 more
GBenign
CD2AP
(D460fs)
Deletion
(frameshift variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(synonymous variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GLikely benign
CD2AP
Single nucleotide variant
(intron variant)
Focal segmental glomerulosclerosis 3, susceptibility to
+1 more
GBenign
CD2AP
Single nucleotide variant
(intron variant)
Focal segmental glomerulosclerosis 3, susceptibility to
+1 more
GBenign
CD2AP
(E525del)
Microsatellite
(inframe_deletion)
not provided
+1 more
GUncertain significance
CD2AP
(P532S)
Single nucleotide variant
(missense variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(intron variant)
not provided
+3 more
GBenign/Likely benign
CD2AP
Single nucleotide variant
(intron variant)
CD2AP-related condition
+2 more
GUncertain significance
CD2AP
(T551A)
Single nucleotide variant
(missense variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GLikely benign
CD2AP
(A558V)
Single nucleotide variant
(missense variant)
not provided
+1 more
GBenign/Likely benign
CD2AP
(K633R)
Single nucleotide variant
(missense variant)
not specified
+3 more
GBenign/Likely benign
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GBenign
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GBenign
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GBenign
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GBenign
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GBenign
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GBenign
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GBenign
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GBenign
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GBenign
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GBenign
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GBenign
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GBenign
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GBenign
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GUncertain significance
CD2AP
Single nucleotide variant
(3 prime UTR variant)
Focal segmental glomerulosclerosis 3, susceptibility to
GBenign
Format
Items per page
Sort by
Choose Destination